Results 131 to 140 of about 354,255 (314)
Re: Risk of End-Stage Renal Disease Following Live Kidney Donation
The authors compare the risk of end-stage renal disease (ESRD) in 96217 kidney donors in the United States, followed for a median of 7.6 years with that of a healthy cohort of 20024 nondonors, followed for a median of 15 years of who are at equally low ...
Muzaale AD +6 more
doaj
ABSTRACT Acute pancreatitis (AP) begins with pancreatic local inflammation, leading to the onset of systemic inflammatory response syndrome (SIRS), followed by compensatory anti‐inflammatory response syndrome (CARS), which causes immune paralysis and higher mortality rate.
Liwei Liu +15 more
wiley +1 more source
Chronic kidney disease: regional variation in Australia [PDF]
Chronic kidney disease (CKD) is a common and serious problem in Australia and its management can be resource intensive. Those with CKD\u27s most severe form, end-stage kidney disease (ESKD), usually require kidney replacement therapy (KRT) to ...
core
Introduction Several studies have suggested, that diabetes is very important factor of the risk of the chronic a renal disease. The paper aims to present a retrospective analysis of incidence of end-stage renal disease in subgroups of patients with and ...
Andrzej Śliwczyński +9 more
core +1 more source
Targeting Lactate and Lactylation in Cancer Metabolism and Immunotherapy
Lactate, once deemed a metabolic waste, emerges as a central regulator of cancer progression. This review elucidates how lactate and its epigenetic derivative, protein lactylation, orchestrate tumor metabolism, immune suppression, and therapeutic resistance.
Jiajing Gong +5 more
wiley +1 more source
Vitamin C and functional iron deficiency anemia in hemodialysis
Yong-Lim Kim
doaj +1 more source
Predictors of quality of life in patients with end-stage renal disease on hemodialysis
Marc M Saad,1 Youssef El Douaihy,1 Christine Boumitri,1 Chetana Rondla,2 Elias Moussaly,1 Magda Daoud,1 Suzanne E El Sayegh3 1Internal Medicine, Staten Island University Hospital, Staten Island, NY, 2Nephrology, Emory University Hospital, Atlanta, GA ...
Moussaly E +6 more
core
β‐Adrenergic Signaling Promotes Anti‐Tumor Immunity in TP53‐mutant Oral Squamous Cell Carcinoma
β‐adrenergic stimulation enhances anti‐tumor immunity in TP53‐deficient oral squamous cell carcinoma by inducing tumor‐derived secretion of CXCL10, which attracts and activates cytotoxic CD8+ T cells. The findings demonstrate that β‐adrenergic signaling alters tumor–immune interactions via CXCL10‐mediated paracrine activation, revealing a neuro‐immune ...
Frederico O. Gleber‐Netto +20 more
wiley +1 more source
Resistant hypertension in pediatric end stage renal disease [PDF]
Virginia Martínez-Santana +3 more
doaj +1 more source
Diabetic End-Stage Renal Disease [PDF]
openaire +2 more sources

